Powered by

-Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2018 Financial Results

Aug 10, 2018 - ENP Newswire

SAN DIEGO - Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the second quarter ended June 30, 2018.

'We have made significant progress over the past three months across our clinical programs, including the initiation of our ADVANCE Phase 3 program for ralinepag in patients with PAH. We are excited for the opportunity to potentially advance the treatment paradigm for patients suffering from this critical illness,' said Amit D. ...